Profiling prostate cancer therapeutic resistance

CA Wade, N Kyprianou - International journal of molecular sciences, 2018 - mdpi.com
The major challenge in the treatment of patients with advanced lethal prostate cancer is
therapeutic resistance to androgen-deprivation therapy (ADT) and chemotherapy …

Therapeutic strategies to target the androgen receptor

W Xiang, S Wang - Journal of Medicinal Chemistry, 2022 - ACS Publications
The androgen receptor (AR) plays a key role in the maintenance of muscle and bone and
the support of male sexual-related functions, as well as in the progression of prostate …

Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer

L Xiao, A Parolia, Y Qiao, P Bawa, S Eyunni, R Mannan… - Nature, 2022 - nature.com
The switch/sucrose non-fermentable (SWI/SNF) complex has a crucial role in chromatin
remodelling and is altered in over 20% of cancers,. Here we developed a proteolysis …

2, 4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer

A Blomme, CA Ford, E Mui, R Patel, C Ntala… - Nature …, 2020 - nature.com
Despite the clinical success of Androgen Receptor (AR)-targeted therapies, reactivation of
AR signalling remains the main driver of castration-resistant prostate cancer (CRPC) …

Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment

S Kregel, C Wang, X Han, L Xiao, E Fernandez-Salas… - Neoplasia, 2020 - Elsevier
Androgen receptor (AR) antagonists, such as enzalutamide, have had a major impact on the
treatment of metastatic castration-resistant prostate cancer (CRPC). However, even with the …

Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide

F Li, M Han, P Dai, W Xu, J He, X Tao, Y Wu… - Nature …, 2021 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly become a global public …

SOX2 mediates metabolic reprogramming of prostate cancer cells

L de Wet, A Williams, M Gillard, S Kregel, S Lamperis… - Oncogene, 2022 - nature.com
New strategies are needed to predict and overcome metastatic progression and therapy
resistance in prostate cancer. One potential clinical target is the stem cell transcription factor …

A positive role of c-Myc in regulating androgen receptor and its splice variants in prostate cancer

S Bai, S Cao, L Jin, M Kobelski, B Schouest, X Wang… - Oncogene, 2019 - nature.com
Increased expression of the full-length androgen receptor (AR-FL) and AR splice variants
(AR-Vs) drives the progression of castration-resistant prostate cancer (CRPC). The levels of …

Therapy-induced lipid uptake and remodeling underpin ferroptosis hypersensitivity in prostate cancer

KD Tousignant, A Rockstroh, BLJ Poad, A Talebi… - Cancer & …, 2020 - Springer
Background Metabolic reprograming, non-mutational epigenetic changes, increased cell
plasticity, and multidrug tolerance are early hallmarks of therapy resistance in cancer. In this …

Prostate cancer extracellular vesicles mediate intercellular communication with bone marrow cells and promote metastasis in a cholesterol‐dependent manner

SE Henrich, KM McMahon… - Journal of …, 2020 - Wiley Online Library
Primary tumours can establish long‐range communication with distant organs to transform
them into fertile soil for circulating tumour cells to implant and proliferate, a process called …